(2R,3S,5R)-2-(hydroxymethyl)-5-(9H-purin-9-yl)tetrahydrofuran-3-ol

Catalog No.: 
ACSKCJ846
CAS No.: 
4546-68-3
Molecular Formula: 
C10H12N4O3
Molecular Weight: 
236.09
(2R,3S,5R)-2-(hydroxymethyl)-5-(9H-purin-9-yl)tetrahydrofuran-3-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%
250mg95%
1g95%
5g95%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,3S,5R)-2-(hydroxymethyl)-5-(9H-purin-9-yl)tetrahydrofuran-3-ol
IUPAC Name(2R,3S,5R)-2-(hydroxymethyl)-5-(9H-purin-9-yl)tetrahydrofuran-3-ol
MDL No.MFCD00672292
Molecular FormulaC10H12N4O3
Molecular Weight236.09
SMILESOC[C@H]1O[C@H](C[C@@H]1O)N2C3=NC=NC=C3N=C2
InChI KeyWJBNIBFTNGZFBW-DJLDLDEBSA-N
Synonym9H-Purine, 9-(2-deoxy-β-D-erythro-pentofuranosyl)-;(2R,3S,5R)-2-(Hydroxymethyl)-5-(9H-purin-9-yl)tetrahydrofuran-3-ol;2’-Deoxynebularine, 6-deamino-2’-deoxy adenosine;2’-Deoxynebularine,;(2R,3S,5R)-2-(Hydroxymethyl)-5-(9H-purin-9-yl)tetrahydrofuran-3-ol - [H89063]
CAS No.4546-68-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACSKCJ846 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNLKS891 route compound structure diagram
    ACNLKS8914594-45-0In Stock
  2. Then
  3. ACSKCJ846 route product structure diagram
    ACSKCJ8464546-68-3In Stock
Inquiry

2. ACSKCJ846 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSKCJ846 route product structure diagram
    ACSKCJ8464546-68-3In Stock
Inquiry

3. ACSKCJ846 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSKCJ846 route product structure diagram
    ACSKCJ8464546-68-3In Stock
Inquiry

Comments (0)